Advanced Biomedical Technologies
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Advanced Biomedical Technologies generated cash of -$734,532, which is more than the previous year. Cash used in financing activities reached the amount of $703,953 last year. Net change in cash is therefore -$32,133.
Cash Flow
| 2013 | -604.96K | -7.60K | 611.18K |
|---|---|---|---|
| 2014 | -732.42K | -23.80K | 782.22K |
| 2015 | -820.39K | -16.41K | 801.97K |
| 2016 | -371.65K | -2.95K | 343.82K |
| 2017 | -557.71K | 760 | 557.75K |
| 2018 | -832.42K | -64.40K | 896.28K |
| 2019 | -742.53K | -18.56K | 759.84K |
| 2020 | 646.66K | -30.70K | -427.82K |
| 2021 | -845.61K | -51.53K | 725.69K |
| 2022 | -734.53K | 0 | 703.95K |
ABMT Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 36.97K | 201.66K | 5.59K | 6.86K | 7.46K | 6.55K | 38.30K | 74.35K | 48.38K | 49.09K |
Operating activities | ||||||||||
Net income | -515.48K | -729.44K | -672K | -948.82K | -953.32K | -691.6K | -724.73K | -862.85K | -827.75K | -890.34K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 18.90K | 41.28K | 60.36K | 21.15K | 16.29K | 13.60K | 29.58K | 30.45K | 26.64K | 26.20K |
Stock-based compensation expense | 0 | 0 | 50.61K | 15.25K | 0 | 0 | 0 | 0 | 0 | 214.66K |
| Deferred income tax benefit | 0 | 0 | 50.61K | 15.25K | 0 | 0 | 0 | 0 | 0 | 214.66K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 30.49K | -47.31K | 23.67K | -17.74K | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | -91.05K | -83.29K | -31.28K | -65.47K | 0 | 0 | 2.68K | -2.82K | 0 | 0 |
Accounts payable | -283.32K | -156.64K | -23.67K | 17.74K | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -734.53K | -845.61K | 646.66K | -742.53K | -832.42K | -557.71K | -371.65K | -820.39K | -732.42K | -604.96K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -51.53K | -30.70K | -18.56K | -64.40K | -453 | -1.69K | -32.31K | -8.79K | -8.16K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | -51.53K | -30.70K | -18.56K | -64.40K | 760 | -2.95K | -16.41K | -23.80K | -7.60K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -755.93K | -44.13K | 0 | 0 | 0 | 0 | 751.59K | 0 | 0 |
Cash used in financing activities | 703.95K | 725.69K | -427.82K | 759.84K | 896.28K | 557.75K | 343.82K | 801.97K | 782.22K | 611.18K |
Net Change In Cash | -32.13K | -164.68K | 196.07K | -1.26K | -603 | 904 | -31.74K | -36.05K | 25.97K | -712 |
Cash at end of period | 4.84K | 36.97K | 201.66K | 5.59K | 6.86K | 7.46K | 6.55K | 38.30K | 74.35K | 48.38K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |